{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T01:17:12Z","timestamp":1750209432867},"reference-count":50,"publisher":"The Japan Society of Coloproctology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Anus Rectum Colon"],"published-print":{"date-parts":[[2023,10,25]]},"DOI":"10.23922\/jarc.2023-033","type":"journal-article","created":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T22:32:44Z","timestamp":1698186764000},"page":"264-272","source":"Crossref","is-referenced-by-count":4,"title":["Effects of Hyperbaric Oxygen Therapy for &lt;i&gt;Clostridioides difficile&lt;\/i&gt;-associated Colitis: A Retrospective Study"],"prefix":"10.23922","volume":"7","author":[{"given":"Daisuke","family":"Muroya","sequence":"first","affiliation":[{"name":"Department of Surgery, Tobata Kyoritsu Hospital"},{"name":"Department of Surgery, Kurume University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Nadayoshi","sequence":"additional","affiliation":[{"name":"Department of Clinical Engineering, Tobata Kyoritsu Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koito","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Clinical Engineering, Tobata Kyoritsu Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaro","family":"Kai","sequence":"additional","affiliation":[{"name":"Department of Clinical Engineering, Tobata Kyoritsu Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Masuda","sequence":"additional","affiliation":[{"name":"Department of Surgery, Tobata Kyoritsu Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takamichi","family":"Nishida","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Tobata Kyoritsu Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Shimokobe","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Tobata Kyoritsu Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Hisaka","sequence":"additional","affiliation":[{"name":"Department of Surgery, Kurume University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10009","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Lawson PA, Diane MC, Kerin LT, et al. Reclassification of Clostridium difficile as Clostridioides difficile (Hall and O&apos;Toole 1935) Prevol 1938. Anaerobe. 2016 Aug; 40: 95-9.","DOI":"10.1016\/j.anaerobe.2016.06.008"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Barbut F, Petit JC. Epidemiology of Clostridium difficile-associated infections. Clin Microbiol Infect. 2016 Aug; 7 (8): 405-10.","DOI":"10.1046\/j.1198-743x.2001.00289.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. He M, Miyajima F, Roberts P, et al. Emergence and global spread of epidemic health care-associated Clostridium difficile. Nat Genet. 2013 Jan; 45 (1): 109-13.","DOI":"10.1038\/ng.2478"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Goorhuis A, Debast SB, van Leengoed LA, et al. Clostridium difficile PCR ribotype 078: an emerging strain in humans and in pigs? J Clin Microbiol. 2008 Mar; 46 (3): 1157-8.","DOI":"10.1128\/JCM.01536-07"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Stevens DL, Bryant AE, Adams K, et al. Evaluation of therapy with hyperbaric oxygen for experimental infection with clostridium perfringens. Clin Infect Dis. 1993 Aug; 17 (2): 231-7.","DOI":"10.1093\/clinids\/17.2.231"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Parra RS, Lopes AH, Carreira EU, et al. Hyperbaric oxygen therapy ameliorates TNBS-induced acute distal colitis in rats. Med Gas Res. 2015 Apr; 16 (5): 6.","DOI":"10.1186\/s13618-015-0026-2"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Yu H, Chen K, Sun Y, et al. Cytokines are markers of the clostridium difficile-induced inflammatory response and predict disease severity. Clin Vaccine Immunol. 2017 Aug; 24 (8): e00037-17.","DOI":"10.1128\/CVI.00037-17"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Benson RM, Minter LM, Osborne BA, et al. Hyperbaric oxygen inhibits stimulus-induced proinflammatory cytokine synthesis by human blood-derived monocyte-macrophages. Clin Exp Immunol. 2003 Oct; 134 (1): 57-62.","DOI":"10.1046\/j.1365-2249.2003.02248.x"},{"key":"9","unstructured":"9. Weisz G, Lavy A, Adir Y, et al. Modification of in vivo and in vitro TNF-alpha, IL-1, and IL-6 secretion by circulating monocytes during hyperbaric oxygen treatment in patients with perianal Crohn&apos;s disease. J Clin Immunol. 1997 Mar; 17 (2): 154-9."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Gonzalez CG, Mills RH, Kordahi MC, et al. The host-microbiome response to hyperbaric oxygen therapy in ulcerative colitis patients. CMGH. 2022 Apr; 14 (1): 35-53.","DOI":"10.1016\/j.jcmgh.2022.03.008"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Song JH, Kim YS. Recurrent Clostridium difficile Infection: Risk Factors, Treatment, and Prevention. Gut Liver. 2019 Mar; 13 (1): 16-24.","DOI":"10.5009\/gnl18071"},{"key":"12","unstructured":"12. Kunishima H, Ohge H, Suzuki H, et al. The Japanese clinical practice guidelines for management of Clostridioides (Clostridium) difficile infections. Kansenshogaku Zasshi J Jpn Assoc Infect Dis. 2018; 92 (6): 819-54."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med. 1994; 330 (4): 257-62.","DOI":"10.1056\/NEJM199401273300406"},{"key":"14","unstructured":"14. Smith LDS, Williams BL. The pathogenic anaerobic bacteria. 3rd ed. Springfield: Thomas."},{"key":"15","unstructured":"15. Brummelkamp WH, Hoogendijk JL, Boerema I. Treatment of anaerobic infections (clostridial myositis) by drenching the tissues with oxygen under high atmospheric pressure. Surgery. 1961; 49: 299-302."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Kuroki K, Masuda A, Uehara H, et al. A new treatment for toxic megacolon. Lancet. 1998 Sep; 352 (9130): 782.","DOI":"10.1016\/S0140-6736(98)95043-7"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Scherbakov A, Malisheva D, Sukhotskaya A, et al. Case report of successful treatment of clostridial colitis in a child using enteral oxygen therapy. Anaesthesiol Intensive Ther. 2022; 54 (1): 97-8.","DOI":"10.5114\/ait.2022.112887"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Schechter R. Is oxygen an antibiotic? Lancet. 1998 Nov; 352 (9139): 1552-3.","DOI":"10.1016\/S0140-6736(05)60361-3"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Cook D, Guyatt G, Marshall J, et al. A comparison of sucrulfate and rantidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. New Engl J Med. 1998 Mar; 338 (12): 791-7.","DOI":"10.1056\/NEJM199803193381203"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kaye D. Effect of hyperbaric oxygen on clostridia in vitro and in vivo. Proc Soc Exp Biol Med. 1967 Feb; 124 (2): 360-6.","DOI":"10.3181\/00379727-124-31743"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Al-Waili NS, Butler GJ. Effects of hyperbaric oxygen on inflammatory response to wound and trauma: possible mechanism of action. Scientific World Journal. 2006 Apr; 6: 425-41.","DOI":"10.1100\/tsw.2006.78"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Madan R, Guo X, Naylor C, et al. Role of leptin-mediated colonic inflammation in defense against Clostridium difficile colitis. Infect Immun. 2014 Jan; 82 (1): 341-9.","DOI":"10.1128\/IAI.00972-13"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Kelly CP, Kyne L. The host immune response to Clostridium difficile. J Med Microbiol. 2011 Aug; 60 (Pt8): 1070-9.","DOI":"10.1099\/jmm.0.030015-0"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. El Feghaly RE, Stauber JL, Deych E, et al. Markers of intestinal inflammation, not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection. Clin Infect Dis. 2013 Jun; 56 (12): 1713-21.","DOI":"10.1093\/cid\/cit147"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Kim H, Kokkotou E, Na X, et al. Clostridium difficile toxin A-induced colonocyte apoptosis involves p53-dependent p21 (WAF1\/CIP1) induction via p38 mitogen-activated protein kinase. Gastroenterology. 2005 Dec; 129 (6): 1875-88.","DOI":"10.1053\/j.gastro.2005.09.011"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Theriot CM, Koumpouras CC, Carlson PE, et al. Cefoperazone-treated mice as an experimental platform to assess differential virulence of Clostridium difficile strains. Gut Microbes. 2011 Dec; 2 (6): 326-34.","DOI":"10.4161\/gmic.19142"},{"key":"27","unstructured":"27. Czepiel J, Biesiada G, Brzozowski T, et al. The role of local systemic cytokines in patients infected with Clostridium difficile. J Physiol Pharmacol. 2014 Oct; 65 (5): 695-703."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Cowardin CA, Kuehne SA, Buonomo EL, et al. Inflammasome activation contributes to interleukin-23 production in response to Clostridium difficile. mBio. 2015 Jan; 6 (1): e02386-14.","DOI":"10.1128\/mBio.02386-14"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Dinarello CA. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int Rev Immunol. 1998; 16 (5-6): 457-99.","DOI":"10.3109\/08830189809043005"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Chen Q, Fisher DT, Clancy KA, et al. Fever-range thermal stress promotes lymphocyte trafficking across high endothelial venules via an interleukin 6 trans-signaling mechanism. Nat Immunol. 2006 Dec; 7 (12): 1299-308.","DOI":"10.1038\/ni1406"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Nishida A, Inoue R, Inatomi O, et al. Gut microbiota in the pathogenesis of inflammatory bowel disease. Clin J Gastroenterol. 2018 Feb; 11 (1): 1-10.","DOI":"10.1007\/s12328-017-0813-5"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science. 2001 May; 292 (5519): 1115-8.","DOI":"10.1126\/science.1058709"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Hooper LV, Midtvedt T, Gordon JI. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu Rev Nutr. 2002; 22: 283-307.","DOI":"10.1146\/annurev.nutr.22.011602.092259"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Wostmann BS. The germfree animal in nutritional studies. Annu Rev Nutr. 1981; 1: 257-79.","DOI":"10.1146\/annurev.nu.01.070181.001353"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Sayin SI, Wahlstrom A, Felin J, et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 2013 Feb; 17 (2): 225-35.","DOI":"10.1016\/j.cmet.2013.01.003"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Winston JA, Theriot CM. Impact of microbial derived secondary bile acids on colonization resistance against <i>Clostridium difficile<\/i> in the gastrointestinal tract. Anaerobe. 2016 Oct; 41: 44-50.","DOI":"10.1016\/j.anaerobe.2016.05.003"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Ridlon JM, Kang DJ, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J Lipid Res. 2006 Feb; 47 (2): 241-59.","DOI":"10.1194\/jlr.R500013-JLR200"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Begley M, Gahan CG, Hill C. The interaction between bacteria and bile. FEMS Microbiol Rev. 2005 Sep; 29 (4): 625-51.","DOI":"10.1016\/j.femsre.2004.09.003"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Theriot CM, Koenigsknecht MJ, Carlson PE Jr, et al. Antibiotic induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nat Commun. 2014; 5: 3114.","DOI":"10.1038\/ncomms4114"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Shen A. A gut odyssey: the impact of the microbiota on Clostridium difficile spore formation and germination. PLoS Pathog. 2015 Oct; 11 (10): e1005157.","DOI":"10.1371\/journal.ppat.1005157"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Sorg JA, Sonenshein AL. Bile salts and glycine as cogerminants for Clostridium difficile spores. J Bacteriol. 2008 Apr; 190 (7): 2505-12.","DOI":"10.1128\/JB.01765-07"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Francis MB, Allen CA, Sorg JA. Muricholic acids inhibit Clostridium difficile spore germination and growth. PLoS One. 2013 Sep; 8 (9): e73653.","DOI":"10.1371\/journal.pone.0073653"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Sorg JA, Sonenshein AL. Inhibiting the initiation of Clostridium difficile spore germination using analogs of chenodeoxycholic acid, a bile acid. J Bacteriol. 2010 Oct; 192 (19): 4983-90.","DOI":"10.1128\/JB.00610-10"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Albenberg L, Esipova TV, Judge CP, et al. Correlation between intraluminal oxygen gradient and radial partitioning of intestinal microbiota. Gastroenterology. 2014 Nov; 147 (5): 1055-63.e8.","DOI":"10.1053\/j.gastro.2014.07.020"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Sinha SR, Haileselassie Y, Nguyen LP, et al. Dysbiosis-induced secondary bile acid deficiency promotes intestinal inflammation. Cell Host Microbe. 2020 Apr; 27 (4): 659-70.e5.","DOI":"10.1016\/j.chom.2020.01.021"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Oya M, Tadano Y, Takihata Y, et al. Effects of hyperbaric conditions on fecal microbiota. Biosci Microbiota Food Health. 2019; 38 (1): 35-9.","DOI":"10.12938\/bmfh.18-016"},{"key":"47","unstructured":"47. Plafki C, Peters P, Almeling M, et al. Complications and side effects of hyperbaric oxygen therapy. Aviat Space Environ Med. 2000 Feb; 71 (2): 119-24."},{"key":"48","unstructured":"48. Camporesi EM. Side effects of hyperbaric oxygen therapy. Undersea Hyperb Med. 2014 May-Jun; 41 (3): 253-7."},{"key":"49","unstructured":"49. Liu WW, Liu K, Mao D, et al. Claustrophobia during routine hyperbaric oxygen treatment. Undersea Hyperb Med. 2012 Jan-Feb; 39 (1): 619-20."},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Bagdasarian N, Rao K, Malani PN. Diagnosis and treatment of Clostridium difficile in adults: a systematic review. JAMA. 2015 Jan; 313 (4): 398-408.","DOI":"10.1001\/jama.2014.17103"}],"container-title":["Journal of the Anus, Rectum and Colon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jarc\/7\/4\/7_2023-033\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T04:45:54Z","timestamp":1715575554000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jarc\/7\/4\/7_2023-033\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,25]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.23922\/jarc.2023-033","relation":{},"ISSN":["2432-3853"],"issn-type":[{"value":"2432-3853","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,25]]},"article-number":"2023-033"}}